BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akhiani AA, Schön K, Franzén LE, Pappo J, Lycke N. Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection. J Immunol. 2004;172:5024-5033. [PMID: 15067084 DOI: 10.4049/jimmunol.172.8.5024] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Tan Z, Liu W, Liu H, Li C, Zhang Y, Meng X, Tang T, Xi T, Xing Y. Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection. European Journal of Pharmaceutics and Biopharmaceutics 2017;111:33-43. [DOI: 10.1016/j.ejpb.2016.11.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 7.6] [Reference Citation Analysis]
2 Egorov AI, Sempértegui F, Estrella B, Egas J, Naumova EN, Griffiths JK. The effect of Helicobacter pylori infection on growth velocity in young children from poor urban communities in Ecuador. Int J Infect Dis 2010;14:e788-91. [PMID: 20638884 DOI: 10.1016/j.ijid.2010.03.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
3 Hickey DK, Aldwell FE, Tan ZY, Bao S, Beagley KW. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection. Vaccine 2009;27:6983-90. [DOI: 10.1016/j.vaccine.2009.09.078] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
4 Peek RM Jr, Fiske C, Wilson KT. Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev. 2010;90:831-858. [PMID: 20664074 DOI: 10.1152/physrev.00039.2009] [Cited by in Crossref: 133] [Cited by in F6Publishing: 128] [Article Influence: 11.1] [Reference Citation Analysis]
5 Akhiani AA, Stensson A, Schön K, Lycke NY. IgA Antibodies Impair Resistance against Helicobacter pylori Infection: Studies on Immune Evasion in IL-10-Deficient Mice. J Immunol 2005;174:8144-53. [DOI: 10.4049/jimmunol.174.12.8144] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
6 Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter. 2007;12:89-102. [PMID: 17309745 DOI: 10.1111/j.1523-5378.2007.00478.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
7 Velin D, Michetti P. Advances in vaccination against Helicobacter pylori. Expert Rev Gastroenterol Hepatol. 2010;4:157-166. [PMID: 20350263 DOI: 10.1586/egh.10.6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
8 Ren WK, Xu YF, Wei WH, Huang P, Lian DW, Fu LJ, Yang XF, Chen FJ, Wang J, Cao HY, Deng YH. Effect of patchouli alcohol on Helicobacter pylori-induced neutrophil recruitment and activation. Int Immunopharmacol. 2019;68:7-16. [PMID: 30599446 DOI: 10.1016/j.intimp.2018.12.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Lina TT, Alzahrani S, Gonzalez J, Pinchuk IV, Beswick EJ, Reyes VE. Immune evasion strategies used by Helicobacter pyloriWorld J Gastroenterol 2014; 20(36): 12753-12766 [PMID: 25278676 DOI: 10.3748/wjg.v20.i36.12753] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
10 Nedrud JG, Bagheri N, Schön K, Xin W, Bergroth H, Eliasson DG, Lycke NY. Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity. PLoS One. 2013;8:e83321. [PMID: 24391754 DOI: 10.1371/journal.pone.0083321] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
11 Gorrell RJ, Wijburg OL, Pedersen JS, Walduck AK, Kwok T, Strugnell RA, Robins-Browne RM. Contribution of secretory antibodies to intestinal mucosal immunity against Helicobacter pylori. Infect Immun 2013;81:3880-93. [PMID: 23918779 DOI: 10.1128/IAI.01424-12] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
12 Müller A, Oertli M, Arnold IC. H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection. Cell Commun Signal. 2011;9:25. [PMID: 22044597 DOI: 10.1186/1478-811x-9-25] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
13 Peng X, Zhang R, Duan G, Wang C, Sun N, Zhang L, Chen S, Fan Q, Xi Y. Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activity. Sci Rep 2018;8:6435. [PMID: 29691472 DOI: 10.1038/s41598-018-24879-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
14 Akhiani AA, Schön K, Lycke N. Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice. J Immunol 2004;173:3348-56. [PMID: 15322198 DOI: 10.4049/jimmunol.173.5.3348] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
15 Gorrell RJ, Robins-Browne RM. Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity. Infect Immun 2009;77:5116-29. [PMID: 19737910 DOI: 10.1128/IAI.00547-09] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
16 Romero-adrián TB, Leal-montiel J, Monsalve-castillo F, Mengual-moreno E, Mcgregor EG, Perini L, Antúnez A. Helicobacter pylori: Bacterial Factors and the Role of Cytokines in the Immune Response. Curr Microbiol 2010;60:143-55. [DOI: 10.1007/s00284-009-9518-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
17 Sjökvist Ottsjö L, Flach CF, Clements J, Holmgren J, Raghavan S. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection. Infect Immun. 2013;81:1532-1540. [PMID: 23439305 DOI: 10.1128/iai.01407-12] [Cited by in Crossref: 54] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
18 Bridgeford EC, Fox JG, Nambiar PR, Rogers AB. Agammaglobulinemia and Staphylococcus aureus botryomycosis in a cohort of related sentinel Swiss Webster mice. J Clin Microbiol 2008;46:1881-4. [PMID: 18322060 DOI: 10.1128/JCM.01875-07] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Milani M, Sharifi Y, Rahmati-Yamchi M, Somi MH, Akbarzadeh A. Immunology and vaccines and nanovaccines for Helicobacter pylori infection. Expert Rev Vaccines. 2015;14:833-840. [PMID: 25645086 DOI: 10.1586/14760584.2015.1008460] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
20 Kim N. Immunological Reactions on H. pylori Infection. In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016. pp. 35-52. [DOI: 10.1007/978-981-287-706-2_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Liu W, Zeng Z, Luo S, Hu C, Xu N, Huang A, Zheng L, Sundberg EJ, Xi T, Xing Y. Gastric Subserous Vaccination With Helicobacter pylori Vaccine: An Attempt to Establish Tissue-Resident CD4+ Memory T Cells and Induce Prolonged Protection. Front Immunol 2019;10:1115. [PMID: 31156652 DOI: 10.3389/fimmu.2019.01115] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
22 Fang Y, Larsson L, Mattsson J, Lycke N, Xiang Z. Mast cells contribute to the mucosal adjuvant effect of CTA1-DD after IgG-complex formation. J Immunol 2010;185:2935-41. [PMID: 20675596 DOI: 10.4049/jimmunol.1000589] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
23 Zhao Y, Zhang J, Cheng ASL, Yu J, To KF, Kang W. Gastric cancer: genome damaged by bugs. Oncogene 2020;39:3427-42. [PMID: 32123313 DOI: 10.1038/s41388-020-1241-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
24 Borlace GN, Keep SJ, Prodoehl MJR, Jones HF, Butler RN, Brooks DA. A role for altered phagosome maturation in the long-term persistence of Helicobacter pylori infection. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012;303:G169-79. [DOI: 10.1152/ajpgi.00320.2011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
25 Hasni SA. Role of Helicobacter pylori infection in autoimmune diseases. Curr Opin Rheumatol. 2012;24:429-434. [PMID: 22617822 DOI: 10.1097/bor.0b013e3283542d0b] [Cited by in Crossref: 41] [Cited by in F6Publishing: 14] [Article Influence: 4.1] [Reference Citation Analysis]
26 Robinson K, Argent RH, Atherton JC. The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol. 2007;21:237-259. [PMID: 17382275 DOI: 10.1016/j.bpg.2007.01.001] [Cited by in Crossref: 109] [Cited by in F6Publishing: 99] [Article Influence: 7.3] [Reference Citation Analysis]
27 Velin D, Bachmann D, Bouzourene H, Michetti P. Reduction of Helicobacter infection in IL-10-/- mice is dependent on CD4+ T cells but not on mast cells. Helicobacter 2008;13:361-9. [PMID: 19250511 DOI: 10.1111/j.1523-5378.2008.00614.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
28 Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology. 2007;133:288-308. [PMID: 17631150 DOI: 10.1053/j.gastro.2007.05.008] [Cited by in Crossref: 167] [Cited by in F6Publishing: 164] [Article Influence: 11.1] [Reference Citation Analysis]
29 Akhiani AA, Stensson A, Schön K, Lycke N. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization. Scand J Immunol. 2006;63:97-105. [PMID: 16476008 DOI: 10.1111/j.1365-3083.2005.01713.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
30 Zhou Z, Gong S, Li X, Yang Y, Guan R, Zhou S, Yao S, Xie Y, Ou Z, Zhao J, Liu Z. Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores. Journal of Medical Microbiology 2015;64:104-10. [DOI: 10.1099/jmm.0.076430-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
31 Algood HM, Allen SS, Washington MK, Peek RM Jr, Miller GG, Cover TL. Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection. J Immunol. 2009;183:5837-5846. [PMID: 19812196 DOI: 10.4049/jimmunol.0901206] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
32 Sheu SM, Sheu BS, Yang HB, Lei HY, Wu JJ. Anti-Lewis X antibody promotes Helicobacter pylori adhesion to gastric epithelial cells. Infect Immun 2007;75:2661-7. [PMID: 17371866 DOI: 10.1128/IAI.01689-06] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
33 Sun YQ, Petersson F, Monstein HJ, Soderholm JD, Rehfeld JF, Borch K. Long-term morpho-functional development of Helicobacter pylori-induced gastritis in Mongolian gerbils. Scand J Gastroenterol. 2005;40:1157-1167. [PMID: 16265773 DOI: 10.1080/00365520510023378] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
34 Salama NR, Hartung ML, Müller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol. 2013;11:385-399. [PMID: 23652324 DOI: 10.1038/nrmicro3016] [Cited by in Crossref: 347] [Cited by in F6Publishing: 323] [Article Influence: 38.6] [Reference Citation Analysis]
35 Taye B, Enquselassie F, Tsegaye A, Amberbir A, Medhin G, Fogarty A, Robinson K, Davey G. Effect of Helicobacter pylori infection on growth trajectories in young Ethiopian children: a longitudinal study. Int J Infect Dis 2016;50:57-66. [PMID: 27531186 DOI: 10.1016/j.ijid.2016.08.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
36 Akhiani AA. The role of type-specific antibodies in colonization and infection by Helicobacter pylori. Curr Opin Infect Dis 2005;18:223-7. [PMID: 15864099 DOI: 10.1097/01.qco.0000168382.86024.14] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
37 Taylor JM, Ziman ME, Fong J, Solnick JV, Vajdy M. Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations. Infect Immun 2007;75:3462-9. [PMID: 17502399 DOI: 10.1128/IAI.01470-06] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
38 Becher D, Deutscher ME, Simpfendorfer KR, Wijburg OL, Pederson JS, Lew AM, Strugnell RA, Walduck AK. Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice. Eur J Immunol. 2010;40:2778-2790. [PMID: 21038469 DOI: 10.1002/eji.200940219] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
39 Chmiela M, Karwowska Z, Gonciarz W, Allushi B, Stączek P. Host pathogen interactions in Helicobacter pylori related gastric cancer. World J Gastroenterol 2017; 23(9): 1521-1540 [PMID: 28321154 DOI: 10.3748/wjg.v23.i9.1521] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]
40 Kaparakis M, Laurie KL, Wijburg O, Pedersen J, Pearse M, van Driel IR, Gleeson PA, Strugnell RA. CD4+ CD25+ regulatory T cells modulate the T-cell and antibody responses in helicobacter-infected BALB/c mice. Infect Immun 2006;74:3519-29. [PMID: 16714584 DOI: 10.1128/IAI.01314-05] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
41 Allison CC, Ferrero RL. Role of virulence factors and host cell signaling in the recognition of Helicobacter pylori and the generation of immune responses. Future Microbiol 2010;5:1233-55. [PMID: 20722601 DOI: 10.2217/fmb.10.84] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
42 Agarwal K, Agarwal S. Helicobacter pylori vaccine: from past to future. Mayo Clin Proc. 2008;83:169-175. [PMID: 18241627 DOI: 10.4065/83.2.169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.1] [Reference Citation Analysis]
43 Algood HM, Cover TL. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev. 2006;19:597-613. [PMID: 17041136 DOI: 10.1128/cmr.00006-06] [Cited by in Crossref: 159] [Cited by in F6Publishing: 80] [Article Influence: 9.9] [Reference Citation Analysis]
44 Avasthi TS, Ahmed N. Helicobacter pylori and type 1 diabetes mellitus: possibility of modifying chronic disease susceptibility with vaccinomics at the anvil. OMICS 2011;15:589-96. [PMID: 21688972 DOI: 10.1089/omi.2010.0138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
45 Souza RC, Lima JH. Helicobacter pylori and gastroesophageal reflux disease: a review of this intriguing relationship. Dis Esophagus. 2009;22:256-263. [PMID: 19425207 DOI: 10.1111/j.1442-2050.2008.00911.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
46 Longet S, Abautret-Daly A, Davitt CJH, McEntee CP, Aversa V, Rosa M, Coulter IS, Holmgren J, Raghavan S, Lavelle EC. An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses. NPJ Vaccines 2019;4:45. [PMID: 31666991 DOI: 10.1038/s41541-019-0139-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
47 Khalilpour A, Osman S, Yunus MH, Santhanam A, Vellasamy N, Noordin R. Helicobacter pylori recombinant UreG protein: cloning, expression, and assessment of its seroreactivity. BMC Res Notes 2014;7:809. [PMID: 25406411 DOI: 10.1186/1756-0500-7-809] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
48 Aebischer T, Meyer TF, Andersen LP. Inflammation, immunity, and vaccines for Helicobacter. Helicobacter. 2010;15 Suppl 1:21-28. [PMID: 21054649 DOI: 10.1111/j.1523-5378.2010.00777.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
49 Spencer J, Boursier L, Edgeworth JD. IgA Plasma Cell Development. In: Kaetzel CS, editor. Mucosal Immune Defense: Immunoglobulin A. Boston: Springer US; 2007. pp. 25-42. [DOI: 10.1007/978-0-387-72232-0_2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Jeremy AH, Du Y, Dixon MF, Robinson PA, Crabtree JE. Protection against Helicobacter pylori infection in the Mongolian gerbil after prophylactic vaccination. Microbes Infect. 2006;8:340-346. [PMID: 16213184 DOI: 10.1016/j.micinf.2005.06.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
51 Raghavan S, Ostberg AK, Flach CF, Ekman A, Blomquist M, Czerkinsky C, Holmgren J. Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach. Infect Immun 2010;78:4251-60. [PMID: 20696831 DOI: 10.1128/IAI.00536-10] [Cited by in Crossref: 46] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
52 Dewayani A, Fauzia KA, Alfaray RI, Waskito LA, Doohan D, Rezkitha YAA, Abdurachman A, Kobayashi T, I'tishom R, Yamaoka Y, Miftahussurur M. The Roles of IL-17, IL-21, and IL-23 in the Helicobacter pylori Infection and Gastrointestinal Inflammation: A Review. Toxins (Basel) 2021;13:315. [PMID: 33924897 DOI: 10.3390/toxins13050315] [Reference Citation Analysis]
53 Arshad U, Sarkar S, Alipour Talesh G, Sutton P. A lack of role for antibodies in regulating Helicobacter pylori colonization and associated gastritis. Helicobacter 2020;25:e12681. [PMID: 32088936 DOI: 10.1111/hel.12681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Sjökvist Ottsjö L, Flach CF, Nilsson S, Malefyt Rde W, Walduck AK, Raghavan S. Defining the Roles of IFN-γ and IL-17A in Inflammation and Protection against Helicobacter pylori Infection. PLoS One 2015;10:e0131444. [PMID: 26168305 DOI: 10.1371/journal.pone.0131444] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
55 Magen E, Schlesinger M, Ben-Zion I, Vardy D. Helicobacter pylori infection in patients with selective immunoglobulin E deficiency. World J Gastroenterol 2015; 21(1): 240-245 [PMID: 25574097 DOI: 10.3748/wjg.v21.i1.240] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
56 Sjökvist Ottsjö L, Jeverstam F, Yrlid L, Wenzel AU, Walduck AK, Raghavan S. Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization. Immunology 2017;150:172-83. [PMID: 27676456 DOI: 10.1111/imm.12676] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
57 Hatzifoti C, Roussel Y, Harris AG, Wren BW, Morrow JW, Bajaj-Elliott M. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori. Helicobacter. 2006;11:113-122. [PMID: 16579841 DOI: 10.1111/j.1523-5378.2006.00385.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
58 Nyström J, Raghavan S, Svennerholm AM. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice. Microbes Infect. 2006;8:442-449. [PMID: 16243563 DOI: 10.1016/j.micinf.2005.07.010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
59 Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23:713-739. [PMID: 20930071 DOI: 10.1128/cmr.00011-10] [Cited by in Crossref: 680] [Cited by in F6Publishing: 383] [Article Influence: 56.7] [Reference Citation Analysis]
60 Zhang S, Moise L, Moss SF. H. pylori vaccines: why we still don’t have any. Hum Vaccin. 2011;7:1153-1157. [PMID: 22048119 DOI: 10.4161/hv.7.11.17655] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
61 Sheu BS, Yang HB, Yeh YC, Wu JJ. Helicobacter pylori colonization of the human gastric epithelium: a bug’s first step is a novel target for us. J Gastroenterol Hepatol. 2010;25:26-32. [PMID: 20136973 DOI: 10.1111/j.1440-1746.2009.06141.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
62 Reyes VE, Peniche AG. Helicobacter pylori Deregulates T and B Cell Signaling to Trigger Immune Evasion. Curr Top Microbiol Immunol 2019;421:229-65. [PMID: 31123892 DOI: 10.1007/978-3-030-15138-6_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
63 Liu M, Zhong Y, Chen J, Liu Y, Tang C, Wang X, Zhang Y, Wang P, Logan SM, Chen W, Wei B. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection. Vaccine 2020;38:3031-41. [PMID: 32139315 DOI: 10.1016/j.vaccine.2020.02.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
64 Dixon BREA, Hossain R, Patel RV, Algood HMS. Th17 Cells in Helicobacter pylori Infection: a Dichotomy of Help and Harm. Infect Immun. 2019;87:e00363-19. [PMID: 31427446 DOI: 10.1128/iai.00363-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
65 Srivastava R, Kashyap A, Kumar M, Nath G, Jain AK. Mucosal IgA & IL-1β in Helicobacter pylori Infection. Indian J Clin Biochem 2013;28:19-23. [PMID: 24381416 DOI: 10.1007/s12291-012-0262-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
66 Anderl F, Gerhard M. Helicobacter pylori vaccination: Is there a path to protection? World J Gastroenterol 2014; 20(34): 11939-11949 [PMID: 25232229 DOI: 10.3748/wjg.v20.i34.11939] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
67 Agarwal K, Agarwal S. Helicobacter pylori Vaccine: From Past to Future. Mayo Clinic Proceedings 2008;83:169-75. [DOI: 10.1016/s0025-6196(11)60838-0] [Cited by in Crossref: 9] [Article Influence: 0.6] [Reference Citation Analysis]
68 Inoue K, Shiota S, Yamada K, Gotoh K, Suganuma M, Fujioka T, Ahmed K, Iha H, Nishizono A. Evaluation of a New Tumor Necrosis Factor-α-Inducing Membrane Protein of Helicobacter pylori as a Prophylactic Vaccine Antigen: H. pylori Tipα Vaccine. Helicobacter 2009;14:487-95. [DOI: 10.1111/j.1523-5378.2009.00713.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]